Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Radiosynthesis of O-3-(2-[18F]fluoroethyl-L-DOPA ([18F]OFED) - a new fluorine-18 labeled phenylalanine derivative

Torsten Kniess, Susann Schroeder, Alexander Hoepping, Joerg Zessin, Frank Fuechtner, Ralf Bergmann and Joerg Steinbach
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1039;
Torsten Kniess
2Helmholtz-Zentrum Dresden-Rossendorf Dresden Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susann Schroeder
2Helmholtz-Zentrum Dresden-Rossendorf Dresden Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Hoepping
1ABX - Advanced Biochemical Compounds Radeberg Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joerg Zessin
2Helmholtz-Zentrum Dresden-Rossendorf Dresden Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Fuechtner
2Helmholtz-Zentrum Dresden-Rossendorf Dresden Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralf Bergmann
2Helmholtz-Zentrum Dresden-Rossendorf Dresden Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joerg Steinbach
2Helmholtz-Zentrum Dresden-Rossendorf Dresden Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1039

Objectives Radiolabeled amino acids such as [11C]methionine, 6-[18F]fluoro-L-dihydroxy phenylalanine ([18F]FDOPA), 3-methoxy-6-[18F]fluoro-L-dihydroxy phenylalanine ([18F]OMFD) and O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) are of great importance for the diagnosis of brain disorders since these amino acid transporter based radiotracers show advantage over [18F]FDG. By searching for new 18F-radiolabeled amino acids, to overcome some limitations of [18F]FDOPA, we have developed a new [18F]fluoroethylated DOPA, [18F]OFED.

Methods The radiosynthesis of [18F]OFED is based on a nucleophilic aliphatic substitution with [18F]fluoride and was performed in an automated synthesizer TracerlabFXN. Briefly the tosylated ethyl group of a triphenyl-di-BOC protected phenylalanine precursor was reacted with a [18F]KF/K222 complex in acetonitrile at 100°C. After deprotection with 2M HCl at 100°C, followed by isolation via semi-preparative HPLC (RP18, water, 1% ethanol) and sterile filtration, [18F]OFED was obtained as injectable solution. [18F]OFED was analyzed for radiochemical and chemical purity, pH-value as well as for residual solvents.

Results A starting activity of 6-17 GBq of [18F]fluoride provided 1.6-5.8 GBq of [18F]OFED within 60 min synthesis time, what corresponds to an overall RCY of 47% (n=6, d.c.). [18F]OFED was obtained with a radiochemical purity of 95-98% and the content of non-radioactive OFED was determined between 0.55 and 2.90 µg/ml resulting in a specific activity of 45-81 GBq/µmol. The pH-value (7.1-7.3) and the content of acetone and acetonitrile (3-14 µg/ml) were found to be in the pharmacologic permitted area.

Conclusions We have developed a new [18F]fluoroethylated DOPA derivative, [18F]OFED, for amino acid transporter based PET diagnostics, which can be synthesized in high yield, specific activity and good pharmaceutical quality.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiosynthesis of O-3-(2-[18F]fluoroethyl-L-DOPA ([18F]OFED) - a new fluorine-18 labeled phenylalanine derivative
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiosynthesis of O-3-(2-[18F]fluoroethyl-L-DOPA ([18F]OFED) - a new fluorine-18 labeled phenylalanine derivative
Torsten Kniess, Susann Schroeder, Alexander Hoepping, Joerg Zessin, Frank Fuechtner, Ralf Bergmann, Joerg Steinbach
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1039;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiosynthesis of O-3-(2-[18F]fluoroethyl-L-DOPA ([18F]OFED) - a new fluorine-18 labeled phenylalanine derivative
Torsten Kniess, Susann Schroeder, Alexander Hoepping, Joerg Zessin, Frank Fuechtner, Ralf Bergmann, Joerg Steinbach
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1039;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

SPECIAL MTA: Preclinical Probes for Neuroimaging Posters

  • Evaluation of Fluorinated TAZA Analogs as Potential Ligands for Aβ Plaques
  • Preliminary in vivo evaluation of a 11C-labeled tetrazine for bioorthogonal reaction within CNS
  • Development of Imaging Methods to Asses Glutamate Function at the NMDA ion channel
Show more SPECIAL MTA: Preclinical Probes for Neuroimaging Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire